Presentations
We introduce lectures and seminars given by ABE & PARTNERS attorneys.
-
"Amgen v. Sanofi/Regeneron in Japan"
placePharma & Biotech Patent Litigation Summit, Europe- Foreign
- IP Disputes
- Life Science and Health Care
- International Disputes
-
"Japan, Pharma and Biotech Patent Litigation Case Law Review"
placePharma & Biotech Patent Litigation Summit, Europe- Foreign
- IP Disputes
- Life Science and Health Care
- International Disputes
-
"Issues with the re-examination system having both a function of ensuring the safety of medicinal products and a function of data protection - The necessity to redesign the re-examination system from both pharmaceutical and IP perspectives -"
placeThe client company (a pharmaceutical company, listed on the Prime Market of Tokyo Stock Exchange)- Domestic
- IP Disputes
- IP Transactions
- Life Science and Health Care
-
"Experimental use exception (Bolar) in Japan"
placeLife Sciences Strategy Summit on IP & Exclusivity- Foreign
- IP Disputes
- Life Science and Health Care
-
"Patent Term Extensions in Japan"
placeLife Sciences Strategy Summit on IP & Exclusivity- Foreign
- IP Disputes
- Life Science and Health Care
-
"Experimental use exception (Bolar) in Japan"
placeLife Sciences IP Summit- Foreign
- IP Disputes
- Life Science and Health Care
-
"Patent Term Extensions in Japan"
placeLife Sciences IP Summit- Foreign
- IP Disputes
- Life Science and Health Care
-
"Patenting Regimen and effect on LCM-analyzing failures and successes in LCM-"
placeTechnical Information Institute- Domestic
- IP Disputes
- Life Science and Health Care
-
"Patent Law"
placeThe client company (a pharmaceutical company, listed on the Prime Market of Tokyo Stock Exchange)- Domestic
- IP Disputes
- Life Science and Health Care
-
"Medical Standard of Care"
placeOsaka University Faculty of Medicine- Domestic
- Life Science and Health Care
-
"Comparative Analysis of Demonstratives in Patent Litigations"
placeWebinar "Patent Litigation and the Use of Demonstrative Exhibits: Perspectives from the U.S. and Japan"- Foreign
- IP Disputes
- Life Science and Health Care
- IT and Telecommunications
- International Disputes
-
"Anti-Corruption"
placethe client company (a cosmetics company)- Domestic
- Life Science and Health Care
- General Corporate
-
"DOE and Cross-Border Infringement of Biologics Process Patent"
placePharma Patent Litigation Summit 2023- Foreign
- IP Disputes
- Life Science and Health Care
- International Disputes
-
"Patent Term Extensions in Japan"
placeLife Science Strategy Summit on IP and Exclusivity- Foreign
- IP Disputes
- Life Science and Health Care
-
"Legal Issues in the Corporate Activities"
placeJapan Intellectual Property Association (Osaka)- Domestic
- IP Disputes
- IP Transactions
- Life Science and Health Care
- IT and Telecommunications
- International Disputes
- Cross-Border Transactions
-
"How to react to IP Disputes"
placeJapan Intellectual Property Association (Osaka)- Domestic
- IP Disputes
- IP Transactions
- Life Science and Health Care
- IT and Telecommunications
- International Disputes
- Cross-Border Transactions
-
"New Inspection System (2019 Patent Act Amendment)"
placeThe Webinar held by Legaltech- Domestic
- IP Disputes
- Life Science and Health Care
- IT and Telecommunications
- International Disputes
-
"Pharmaceutical Patent Litigation and Regulation in Japan"
placeThe client company (a pharmaceutical company)- Foreign
- IP Disputes
- Life Science and Health Care
- International Disputes
-
"Experimental Use Exception in Japan"
placeAIPPI Pharma Committee- Foreign
- IP Disputes
- Life Science and Health Care
-
"Japan Suffers From Trade Secret Infringement"
placeWIPR Patents Live- Foreign
- IP Disputes
- Life Science and Health Care
- IT and Telecommunications
-
"Experimental Use Exception in Japan"
placeAIPPI Pharma Committee- Foreign
- IP Disputes
- Life Science and Health Care
-
"Will Authorised Biologics Deter Biosimilars?-Utilising JFTC’s Expertise in Drug Pricing"
placeLSPN Connect- Foreign
- Life Science and Health Care
- Antitrust/Competition
-
"Medical Standard of Care"
placeOsaka University Faculty of Medicine- Domestic
- Life Science and Health Care
-
"New IP Mediation Proceedings, New Inspection System"
placeThe Shikoku Branch of Japan Patent Attorneys Association- Domestic
- IP Disputes
- Life Science and Health Care
- IT and Telecommunications
- International Disputes
-
"Viewpoint of Trademark case- how to overturn losing decision at JPO -"
placeJapan Trademark Association- Domestic
- IP Disputes
- Life Science and Health Care
- IT and Telecommunications
-
"A closer look at Japan’s desirable patent system in the era of COVID-19"
placeOsaka Institute of Invention and Innovation- Domestic
- IP Disputes
- IP Transactions
- Life Science and Health Care
- IT and Telecommunications
- International Disputes
- Cross-Border Transactions
-
"Why reverse payment is unlikely to arise in Japan?"
placeKTK- Domestic
- IP Disputes
- Life Science and Health Care
- Antitrust/Competition
-
"Do Clinical Trials for Original Drugs Fall Under The Experimental Use Exception?"
placeLSPN Connect- Foreign
- IP Disputes
- Life Science and Health Care
-
"How has Japanese patent litigation been reformed?"
placeWIPR Patents Live- Foreign
- IP Disputes
- Life Science and Health Care
- IT and Telecommunications
- International Disputes
- Antitrust/Competition
-
"A new drug pricing system reform proposal in Japan - To balance setting the upper limit of total drug expenditure with appropriate evaluation of the value of innovative drugs"
placeLSPN Connect- Foreign
- Life Science and Health Care
-
"Trade secret and punitive damages in IP"
placeAPABA Silicon Valley- Foreign
- IP Disputes
- Life Science and Health Care
- IT and Telecommunications
- International Disputes
- Antitrust/Competition
-
"Why the first penguin of Pay for Delay has not come in Japan-Anatomy of the Japanese Paradox-"
placeLSPN Connect- Foreign
- IP Disputes
- Life Science and Health Care
- Antitrust/Competition
-
"Clinical trials for original drugs fall under experimental use exception"
placeLSPN Connect- Foreign
- IP Disputes
- Life Science and Health Care
-
"Clinical trials for original drugs fall under experimental use exception"
placeThe client company (a pharmaceutical company)- Foreign
- IP Disputes
- Life Science and Health Care
-
"A closer look at Japan’s desirable patent system in the era of COVID-19"
placeKTK- Domestic
- IP Disputes
- IP Transactions
- Life Science and Health Care
- IT and Telecommunications
- International Disputes
- Cross-Border Transactions
-
"Function or Sequence? Antibody Patents in Japan after Baxalta v. Chugai/Amgen v. Sanofi."
placeLSPN Connect- Foreign
- IP Disputes
- Life Science and Health Care
- International Disputes
-
"Patenting Antibodies - Antibody Patents in Japan after Baxalta v.Chugai/Amgen v. Sanofi- Function or Sequence?"
placeIP Life Sciences Conference- Foreign
- IP Disputes
- Life Science and Health Care
- International Disputes
-
"Patenting Antibodies - Antibody Patents in Japan after Baxalta v. Chugai/Amgen v. Sanofi- Function or Sequence?"
placeLSPN Connect Live- Foreign
- IP Disputes
- Life Science and Health Care
- International Disputes
-
"What Does the Future Hold for Reverse-Payment Settlement Litigation, Patent Thicketing and Restrictive Distribution Agreements?"
placeACI’s premiere conference on Life Sciences Antitrust- Foreign
- IP Disputes
- Life Science and Health Care
- International Disputes
- Antitrust/Competition
-
"Antibody Patents After Amgen v. Sanofi"
placeACI’s 19th Global Summit on Life Sciences Patents- Foreign
- IP Disputes
- Life Science and Health Care
- International Disputes
-
"U.S. Patent Litigation Update: The Resurgence of Patent Trolls"
placethe seminar jointly with Akin Gump Strauss Hauer & Feld LLP- Domestic
- IP Disputes
- Life Science and Health Care
- IT and Telecommunications
- International Disputes
-
"New IP Mediation Proceedings, New Inspection System"
placethe seminar organized by Research Institute of Economy, Trade and Industry- Domestic
- IP Disputes
- Life Science and Health Care
- IT and Telecommunications
- International Disputes
-
"Medical Standard of Care"
placeOsaka University Faculty of Medicine- Domestic
- Life Science and Health Care
-
"How was Japanese patent litigation reformed?"
place9th edition of World IP Forum- Foreign
- IP Disputes
- Life Science and Health Care
- IT and Telecommunications
- International Disputes
- Antitrust/Competition
-
"Complying with Licesing and Product Requirements"
placeThe 8th Annual Conference on Cosmetics & Personal Care Products- Foreign
- IP Disputes
- Life Science and Health Care
- International Disputes
-
"How was Japanese Patent Litigation Reformed?"
placeThe client company (an information technology company)- Foreign
- IP Disputes
- Life Science and Health Care
- IT and Telecommunications
- International Disputes
- Antitrust/Competition
-
"Japanese pharmaceutical patent cases and regulatory issues"
placeThe client company (a pharmaceutical company)- Foreign
- IP Disputes
- Life Science and Health Care
- International Disputes
-
"Japanese pharmaceutical patent cases and regulatory issues"
placeThe client company (a pharmaceutical company)- Foreign
- IP Disputes
- Life Science and Health Care
- International Disputes
-
"New IP Mediation Proceedings, New Inspection System"
placeThe client company (an automobile parts manufacturing company listed with first section of the Tokyo Stock Exchange)- Domestic
- IP Disputes
- Life Science and Health Care
- IT and Telecommunications
- International Disputes
-
"New IP Mediation Proceedings, New Inspection System"
placeThe client company (a chemical company listed with first section of the Tokyo Stock Exchange)- Domestic
- IP Disputes
- Life Science and Health Care
- IT and Telecommunications
- International Disputes